Document is current
Any future updates will be listed below
-
Authors
Dissanayaka, Nadeeka https://orcid.org/0000-0002-0164-3337
Pourzinal, Dana
Byrne, Gerard J.
Yang, Jihyun
McMahon, Katie L.
Pontone, Gregory M.
O’Sullivan, John D.
Adam, Robert
Littleford, Roberta
Chatfield, Mark
Lehn, Alexander
Mari, Zoltan
Bakker, Arnold
-
Funding
Funding for this research was provided by:
Royal Brisbane and Women's Hospital Foundation
- License Information
-
More Information
Article History
Received: 18 September 2022
Accepted: 16 October 2023
First Online: 22 November 2023
Declarations
:
: Ethical approval has been received from the Royal Brisbane and Women’s Hospital (HREC/2020QRBW/69379) and the University of Queensland (20200002745) Human Research Ethics Committees (HREC). Written informed consent is elicited from all participants prior to the commencement of the study.
: Not applicable.
: A.B. is an inventor in Johns Hopkins University’s intellectual property related to this work with patents pending and licensed to AgeneBio. A.B. is a consultant for Acadia Pharmaceuticals, Inc. A.B.’s role in the current study was in compliance with the conflict of interest policies of the Johns Hopkins School of Medicine. G.P. is a consultant for Acadia Pharmaceuticals and Concert Pharmaceuticals; he has no conflict of interest relevant to the proposed work. Z.M. has been a paid consultant for Global Kinetics Corporation, AbbVie, and Supernus; he has no conflict of interest relevant to the current study. J.O.S. is a consultant for AbbVie and Ipsen; he has no conflict of interest relevant to the current study. The other authors declare that they have no competing interests.
